In the BioHarmony Drug Report Database

"Preview" Icon

Pravastatin

Pravachol, Pravafenix (pravastatin) is a small molecule pharmaceutical. Pravastatin was first approved as Pravachol on 1991-10-31. It is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. It has been approved in Europe to treat dyslipidemias. The pharmaceutical is active against 3-hydroxy-3-methylglutaryl-Coenzyme A reductase. In addition, it is known to target solute carrier organic anion transporter family member 1B1.

 

Trade Name

 

Pravafenix
 

Common Name

 

pravastatin
 

ChEMBL ID

 

CHEMBL1144
 

Indication

 

coronary artery disease, dyslipidemias, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia
 

Drug Class

 

Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

Image (chem structure or protein)

Pravastatin structure rendering